Balkan Pharma-Dupnitsa

Balkanpharma-Dupnitsa is a prominent pharmaceutical manufacturing facility located in Dupnitsa, Bulgaria, and currently operates as a strategic subsidiary of Teva Pharmaceuticals. Originally established in 1954, the site evolved from a state-owned enterprise into a cornerstone of the Balkanpharma group before its acquisition by Actavis and later Teva. The facility specializes in the large-scale production of generic small molecule drugs, primarily in solid oral dosage forms such as tablets and capsules. It is recognized as one of the largest and most technologically advanced pharmaceutical plants in Southeast Europe, maintaining rigorous GMP standards. The site exports a wide range of medicines to international markets, covering therapeutic areas including cardiovascular, central nervous system, and respiratory health. As a vital part of Teva's global supply chain, Balkanpharma-Dupnitsa continues to be a major regional employer and a key contributor to the Bulgarian life sciences sector.